MC
BIO icon

Menta Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Menta Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,380
Closed -$432K – 549
2018
Q3 		$432K Sell
1,380
-3
-0.2% -$931 0.15% 254
2018
Q2 		$399K Sell
1,383
-57
-4% -$15.7K 0.09% 393
2018
Q1 		$360K Sell
1,440
-1,062
-42% -$270K 0.08% 423
2017
Q4 		$597K Sell
2,502
-1,741
-41% -$422K 0.12% 316
2017
Q3 		$943K Sell
4,243
-2,920
-41% -$657K 0.14% 271
2017
Q2 		$1.62M Buy
7,163
+1,196
+20% +$261K 0.19% 186
2017
Q1 		$1.19M Buy
+5,967
New +$1.15M 0.12% 294
2015
Q1 		– Sell
-7,660
Closed -$923K – 691
2014
Q4 		$923K Buy
+7,660
New +$882K 0.13% 273

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.31B AUM 28.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return